What helps with withdrawals from alcohol
Pro Research Analysisby 
Searched over 200M research papers
Effective Treatments for Alcohol Withdrawal
Benzodiazepines for Alcohol Withdrawal
Benzodiazepines are widely recognized as the gold standard for treating alcohol withdrawal syndrome (AWS). They are effective in reducing withdrawal symptoms, preventing seizures, and managing delirium tremens3 5 6. Commonly used benzodiazepines include chlordiazepoxide, diazepam, and lorazepam, which can be administered using various regimens such as front-loading, fixed-dose, or symptom-triggered approaches3 6. Studies have shown that benzodiazepines significantly reduce the risk of seizures compared to placebo and are generally safe and effective7.
Intranasal Oxytocin
Recent research has highlighted the potential of intranasal oxytocin (OT) in managing alcohol withdrawal. A clinical trial demonstrated that OT significantly reduced withdrawal symptoms, decreased the need for lorazepam, and improved mood states in alcohol-dependent subjects1. This suggests that OT could be a promising alternative to traditional benzodiazepine therapy, potentially reversing sedative-hypnotic tolerance rather than maintaining it1.
Gamma-Hydroxybutyrate (GHB)
Gamma-hydroxybutyrate (GHB) has shown efficacy in treating AWS and preventing relapse. Studies indicate that GHB can effectively reduce withdrawal symptoms and improve abstinence rates compared to placebo and other treatments like naltrexone and disulfiram2. However, concerns about the potential for addiction and misuse, particularly among polydrug abusers, necessitate careful consideration and monitoring when using GHB2.
Anticonvulsants
Non-benzodiazepine anticonvulsants (NBACs) such as carbamazepine and gabapentin are increasingly used for managing AWS, especially in outpatient settings. These medications are beneficial for mild to moderate withdrawal symptoms and can be used as adjunctive treatments alongside benzodiazepines3 10. Gabapentin, in particular, is noted for its ease of use, rapid titration, and good tolerability, making it a viable option for both withdrawal management and reducing the risk of relapse10.
Adjunctive Treatments
Other medications, including α2-agonists (clonidine and dexmedetomidine) and β-blockers, can be used as adjunctive treatments to control neuroautonomic hyperactivity associated with AWS3 5. Neuroleptic agents may also help manage hallucinations, although they should not be used as monotherapy6.
Conclusion
Effective management of alcohol withdrawal involves a combination of pharmacologic interventions tailored to the severity of symptoms and individual patient characteristics. Benzodiazepines remain the cornerstone of treatment, but alternatives like intranasal oxytocin, GHB, and anticonvulsants offer promising results. Adjunctive therapies can further enhance treatment outcomes, ensuring a comprehensive approach to managing AWS.
Sources and full results
Most relevant research papers on this topic